BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 27, 2005
View Archived Issues
Invitrogen Adding New Products Via $130M BioSource Purchase
In order to grow in the area of proteomics, Invitrogen Corp. signed a definitive agreement to acquire BioSource International Inc. for about $130 million in cash. (BioWorld Today)
Read More
Genitope's Stock Tumbles As MyVax's Phase III Continues
Read More
Kirin Buys Transgenic Cow Firm Hematech For $45M
Read More
Valeant Prepares For Phase III Retigabine Studies In Epilepsy
Read More
Correction
Read More
Other News To Note
Read More